This section describes efficacy outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see ...

At the tail end of 2011, a report in Bloomberg Businessweek highlighted a growing problem in the $300 billion pain market: the increase in severe and unexpected complications for patients who undergo ...

The following column first appeared in the AAPC News.Medicare Part B physician payments for transforaminal epidural injection services increased from $57 million in 2003 to $141 million in 2007, ...